2025 Packaging Vaccines 
Express Pharma
JUNE 3, 2024
mRESVIA is Moderna’s second approved product and reportedly the only RSV vaccine available in single-dose pre-filled syringes Moderna, announced that the U.S. This approval is also the first time an mRNA vaccine has been approved for a disease other than COVID-19. package insert. The primary analysis with 3.7
Pharmaceutical Technology
NOVEMBER 1, 2022
“The medicines regulators in Europe have a strategy for 2025 where the second pillar is data and digitalisation, so we are trying to transform medicines regulation to be data-driven,” says Peter Arlett, Head of Data Analytics and Methods Task Force at EMA. Arlett explains that Darwin EU is playing a collaborative role in this goal.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 22, 2023
According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.
Fuld & Company Blog
MAY 15, 2023
In addition, in-person care would be available for follow-up care, vaccinations, or blood draws through a registered nurse who would be made available at a location of the patients’ choosing, at home or in the office. Soon after its soft launch, Amazon began testing the idea with potential corporate clients, but had little success.
Pharmaceutical Technology
NOVEMBER 22, 2022
The Chinese government announced its ten-year 'Made in China 2025' strategic plan in 2015, which aimed to make the country a global leader in several high-tech industries. These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognised for generics production.
Quality Matters
APRIL 19, 2024
Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.
European Pharmaceutical Review
MAY 14, 2024
At its Le Trait site in Normandy, Sanofi added that it will devote €100 million for new capacity for biologics formulation, filling, device assembly and packaging. Sanofi shared that it plans to launch in 2025. An investment of €250 million will used to build Europe’s largest flu vaccine production unit in Val de Reuil.
Expert insights. Personalized for you.
81 
Let's personalize your content